Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$2.49B |
| 2 |
NVIDIA
NVDA
|
+$2.19B |
| 3 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$1.94B |
| 4 |
TSMC
TSM
|
+$728M |
| 5 |
UnitedHealth
UNH
|
+$705M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$775M |
| 2 |
AbbVie
ABBV
|
+$540M |
| 3 |
Delta Air Lines
DAL
|
+$434M |
| 4 |
Eli Lilly
LLY
|
+$433M |
| 5 |
DexCom
DXCM
|
+$433M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 4.89% |
| 2 | Healthcare | 2.92% |
| 3 | Financials | 2.71% |
| 4 | Consumer Discretionary | 2.52% |
| 5 | Industrials | 2.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PAYM
7376
TrueShares S&P Autocallable Defensive Income ETF
PAYM
$129M
| $987K | ﹤0.01% |
+39,673
| New | +$989K |
|
7377
CALL
ASE Group
ASX
$79.7B
| $987K | ﹤0.01% |
+61,300
| New | +$871K |
|
7378
CALL
Revvity
RVTY
$12.8B
| $987K | ﹤0.01% |
10,200
+5,100
| +100% | +$490K |
|
|
REFI
7379
Chicago Atlantic Real Estate Finance
REFI
$253M
| $986K | ﹤0.01% |
+80,463
| New | +$1.03M |
|
|
AFIX
7380
Allspring Broad Market Core Bond ETF
AFIX
$200M
| $986K | ﹤0.01% |
39,303
-202,814
| -84% | -$5.13M |
|
|
VTYX
7381
CALL
DELISTED
Ventyx Biosciences
VTYX
| $986K | ﹤0.01% |
109,200
+65,400
| +149% | +$489K |
|
|
AUSM
7382
Allspring Ultra Short Municipal ETF
AUSM
$33.1M
| $986K | ﹤0.01% |
39,287
+28,158
| +253% | +$707K |
|
7383
CALL
National Health Investors
NHI
$3.69B
| $985K | ﹤0.01% |
12,900
+4,000
| +45% | +$307K |
|
7384
PUT
Arcutis Biotherapeutics
ARQT
$3.21B
| $984K | ﹤0.01% |
33,900
+6,800
| +25% | +$174K |
|
7385
PUT
Itron
ITRI
$4.44B
| $984K | ﹤0.01% |
10,600
+5,700
| +116% | +$621K |
|
7386
Foghorn Therapeutics
FHTX
$272M
| $984K | ﹤0.01% |
182,276
+170,249
| +1,416% | +$772K |
|
7387
PUT
Funko
FNKO
$328M
| $984K | ﹤0.01% |
289,300
-57,200
| -17% | -$180K |
|
7388
PUT
Rayonier
RYN
$6.49B
| $983K | ﹤0.01% |
45,416
-15,206
| -25% | -$344K |
|
7389
CALL
Middlesex Water
MSEX
$1.08B
| $983K | ﹤0.01% |
19,500
+6,200
| +47% | +$333K |
|
|
RKLX
7390
PUT
Defiance Daily Target 2X Long RKLB ETF
RKLX
$186M
| $983K | ﹤0.01% |
+24,700
| New | +$907K |
|
7391
SandRidge Energy
SD
$504M
| $982K | ﹤0.01% |
+68,018
| New | +$900K |
|
7392
CALL
Reynolds Consumer Products
REYN
$5.29B
| $981K | ﹤0.01% |
42,800
+32,800
| +328% | +$791K |
|
7393
FlexShares Disciplined Duration MBS Index Fund
MBSD
$88.6M
| $980K | ﹤0.01% |
47,174
+33,776
| +252% | +$705K |
|
7394
PUT
Civeo
CVEO
$342M
| $979K | ﹤0.01% |
42,800
-25,900
| -38% | -$575K |
|
7395
Arteris
AIP
$1.39B
| $979K | ﹤0.01% |
+63,143
| New | +$915K |
|
7396
PUT
iShares Russell 2000 Value ETF
IWN
$14.5B
| $979K | ﹤0.01% |
5,400
-500
| -8% | -$89.8K |
|
7397
US Treasury 20 Year Bond ETF
UTWY
$8.23M
| $978K | ﹤0.01% |
22,494
+16,678
| +287% | +$738K |
|
7398
CALL
Artisan Partners
APAM
$2.94B
| $978K | ﹤0.01% |
24,000
-28,800
| -55% | -$1.23M |
|
|
DYNB
7399
Hartford Dynamic Bond ETF
DYNB
$62.2M
| $977K | ﹤0.01% |
24,561
+68
| +0.3% | +$2.72K |
|
|
GNTA
7400
Genenta Science
GNTA
$68M
| $976K | ﹤0.01% |
655,164
+642,678
| +5,147% | +$1.51M |
|
Similar funds
Citadel Advisors's Q4 2025 Portfolio in Review
As of Q4 2025, Citadel Advisors held 14,701 positions worth $666B, up 1.3% from $657B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Citadel Advisors's Q4 2025 filing shows 2,078 new, 5,000 increased, 5,363 reduced and 2,191 closed positions. Its largest new stake was Medline Inc: 6,006,339 shares worth $252M. The largest sale was Meta Platforms (Facebook), an estimated $775M.
By sector, the portfolio is most concentrated in Technology at 4.9% of assets, up from 3.8% a quarter earlier, followed by Healthcare and Financials.
- Citadel Advisors's largest Q4 2025 buy was Medline Inc: 6,006,339 shares worth $252M.
- Citadel Advisors added most to Amazon in Q4 2025, an estimated $2.49B increase.
- Citadel Advisors's biggest Q4 2025 reduction was Meta Platforms (Facebook), cutting an estimated $775M.
- Citadel Advisors fully exited WEX in Q4 2025, selling an estimated $131M.
- Citadel Advisors's ten largest holdings make up 23% of its $666B portfolio in Q4 2025.
- Citadel Advisors opened 2,078 new positions and closed 2,191 in Q4 2025.
- Citadel Advisors's portfolio value rose 1.3% quarter-over-quarter to $666B.
Based on Citadel Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.